Nilstat and Crestor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nilstat (nystatin) and Crestor (rosuvastatin calcium). Common drug interactions include chronic obstructive pulmonary disease among females and blood creatine phosphokinase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Nilstat and Crestor. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Nilstat?

Nilstat has active ingredients of nystatin. eHealthMe is studying from 498 Nilstat users. Check the latest studies of Nilstat.

What is Crestor?

Crestor has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 149,761 Crestor users. Check the latest studies of Crestor.



On Jul, 12, 2026

18 people who take Nilstat and Crestor together, and have interactions are studied.

Nilstat and Crestor drug interactions.

What are the common drug interactions of Nilstat and Crestor, by gender? *:

female:

  1. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  2. General physical health deterioration (weak health status)
  3. Pneumonia
  4. Pneumonia pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa)
  5. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  6. Pyrexia (fever)
  7. Abdominal neoplasm (cancer of the stomach)
  8. Adenocarcinoma pancreas (cancer of pancreas)
  9. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  10. Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)

male:

  1. Blood creatine phosphokinase increased
  2. Renal failure (kidney dysfunction)
  3. Hepatitis (inflammation of the liver)
  4. Lethargy (tiredness)
  5. Tinnitus (a ringing in the ears)
  6. Hypertension (high blood pressure)
  7. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  8. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Pancreatitis (inflammation of pancreas)

What are the common drug interactions of Nilstat and Crestor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blood creatine phosphokinase increased
  2. Renal failure (kidney dysfunction)
  3. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Pancreatitis (inflammation of pancreas)
  6. Hypertriglyceridaemia (excess of triglycerides in the blood)

50-59:

  1. Arthralgia (joint pain)
  2. Deafness unilateral
  3. Hepatitis (inflammation of the liver)
  4. Lethargy (tiredness)
  5. Tinnitus (a ringing in the ears)

60+:

  1. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  2. General physical health deterioration (weak health status)
  3. Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)
  4. Fall
  5. Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
  6. Jaundice cholestatic
  7. Limb injury
  8. Low density lipoprotein increased (cholesterol increased in blood)
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Myalgia (muscle pain)

What are the existing conditions these people have? *

  1. Pain: 5 people, 27.78%
  2. Insomnia (sleeplessness): 4 people, 22.22%
  3. Constipation: 4 people, 22.22%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 22.22%
  5. High Blood Pressure: 4 people, 22.22%
  6. Prostate Cancer: 3 people, 16.67%
  7. Hypokalemia (low potassium): 2 people, 11.11%
  8. Dyspnea (difficult or laboured breathing): 2 people, 11.11%
  9. Fever: 2 people, 11.11%
  10. Hot Flush (sudden feelings of heat): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Nilstat and Crestor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nilstat and Crestor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nilstat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Crestor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nilstat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Crestor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nystatin and rosuvastatin calcium (the active ingredients of Nilstat and Crestor, respectively), and Nilstat and Crestor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: